Showing 121 - 140 results of 37,744 for search '(( 5 ((ppm decrease) OR (mean decrease)) ) OR ( a ((non decrease) OR (point decrease)) ))', query time: 0.60s Refine Results
  1. 121
  2. 122
  3. 123
  4. 124

    Decreased MBP levels in the brain in <i>Large</i><sup><i>myd/myd</i></sup> mice. by Shigefumi Morioka (8893511)

    Published 2020
    “…The results are presented as the mean of at least three experiments. <b>B,</b> Whole-brain lysates of P7 control and <i>Large</i><sup><i>myd/myd</i></sup> mice (<i>n</i> = 5) were obtained for MBP immunoblotting. …”
  5. 125
  6. 126
  7. 127
  8. 128

    The mean and standard deviation of parameters. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    “…Additionally, one-way ANCOVA revealed a significant difference between the groups post-treatment (F(1,31) = 6.011, P = 0.020, η2 = 0.162) and one month post-treatment (F(1,31) = 4.889, P = 0.035, η2 = 0.136), with ML SI being significantly lower in the exergaming group than the balance training group at both time points. …”
  9. 129
  10. 130
  11. 131
  12. 132
  13. 133
  14. 134
  15. 135

    Annual number of outpatient visits in all eyes. by Yasuyuki Sotani (20114144)

    Published 2025
    “…In the recurrence group, BCVA (logMAR) showed no significant improvement over time: 0.37 ± 0.20 preoperatively and 0.35 ± 0.23, 0.35 ± 0.18, 0.31 ± 0.23, 0.34 ± 0.26, 0.28 ± 0.30, and 0.24 ± 0.23 at 1, 3, 6, 12, 24, and 36 months, respectively (Kruskal-Wallis test, p = 0.45). In contrast, the non-recurrence group demonstrated significant and sustained improvement from 0.31 ± 0.25 preoperatively to 0.25 ± 0.25, 0.23 ± 0.26, 0.23 ± 0.28, 0.21 ± 0.27, 0.20 ± 0.30, and 0.16 ± 0.30 at corresponding postoperative time points (Kruskal-Wallis test, p < 0.001; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0332941#pone.0332941.g005" target="_blank">Fig 5</a>).…”
  16. 136
  17. 137
  18. 138
  19. 139
  20. 140